News

Heart valve disease is a serious cardiovascular condition which can be fatal if left untreated. Following on from our Heart Health Survey, Global Heart Hub’s Heart Valve Disease Patient Council has partnered with The Health Policy Partnership, an independent health policy research organisation, to develop a report aiming to raise stakeholder awareness of heart valve disease across Europe.

Heart Valve Voice’s new partnership with the UK Valve For Life initiative could not have come at a more critical time for valve disease patients, according to CEO, Wil Woan. The initiative is run by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and will be promoting transcatheter valve interventions, which could be crucial in rapidly reducing the waiting lists built up during the COVID-19 crisis.

In recent weeks and months, we have spoken to patients whose heart valve disease treatment have been delayed due to COVID-19. Now, we have begun to publish stories that give the real-life experience of the impact of these delays on individuals.

COVID-19 has placed a huge strain on the NHS and led to the delay of thousands of appointments and heart valve disease treatments. But behind every number is a story, and this is the story of Patient 428. All individual's identities have been kept anonymous.

COVID-19 has placed a huge strain on the NHS and led to the delay of thousands of appointments and heart valve disease treatments. But behind every number is a story, and this is the story of Patient 229. All individual's identities have been kept anonymous.

COVID-19 has placed an extraordinary strain on our lives, our communities and our NHS. Because of this pressure, thousands of patients have experienced delays to treatments. While we understand that tough decisions need to be made to ease the strain on our NHS, we have a simple message to our care centres - just treat us.